In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, ...

DNA-tagged gold nanoparticles Andy Tay 1Asst Prof Andy Tay (right) and Ms Huang Xingyue (left) from NUS have developed a ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company ...

The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds marbaloxavir and favipiravir while removing amantadine and rimantadine.

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.